ALPS Medical Breakthroughs ETF (SBIO)
NYSEARCA: SBIO · Real-Time Price · USD
57.56
-0.99 (-1.69%)
Sep 25, 2026, 4:00 PM EDT - Market closed
SBIO Holdings Information
SBIO is an equity ETF with a total of 104 individual holdings. The top holdings are CG Oncology stock at 3.79%, Travere Therapeutics at 3.56%, Oruka Therapeutics at 3.52%, Dianthus Therapeutics at 3.16%, and Definium Therapeutics at 3.07%.
Total Holdings
104
Top 10 Percentage
30.04%
Asset Class
Equity
ETF Category
Health
Assets
217.23M
PE Ratio
n/a
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | CGON | CG Oncology, Inc. | 3.79% |
| 2 | TVTX | Travere Therapeutics, Inc. | 3.56% |
| 3 | ORKA | Oruka Therapeutics, Inc. | 3.52% |
| 4 | DNTH | Dianthus Therapeutics, Inc. | 3.16% |
| 5 | DFTX | Definium Therapeutics, Inc. | 3.07% |
| 6 | MANE | Veradermics, Incorporated | 3.01% |
| 7 | EWTX | Edgewise Therapeutics, Inc. | 2.78% |
| 8 | RLAY | Relay Therapeutics, Inc. | 2.42% |
| 9 | ACAD | ACADIA Pharmaceuticals Inc. | 2.38% |
| 10 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.35% |
| 11 | XENE | Xenon Pharmaceuticals Inc. | 2.29% |
| 12 | IDYA | IDEAYA Biosciences, Inc. | 2.21% |
| 13 | TARS | Tarsus Pharmaceuticals, Inc. | 2.07% |
| 14 | DNLI | Denali Therapeutics Inc. | 2.04% |
| 15 | DYN | Dyne Therapeutics, Inc. | 1.92% |
| 16 | ZLAB | Zai Lab Limited | 1.77% |
| 17 | NAMS | NewAmsterdam Pharma Company N.V. | 1.69% |
| 18 | MBX | MBX Biosciences, Inc. | 1.66% |
| 19 | GPCR | Structure Therapeutics Inc. | 1.60% |
| 20 | IRON | Disc Medicine, Inc. | 1.59% |
| 21 | IMNM | Immunome, Inc. | 1.58% |
| 22 | CLDX | Celldex Therapeutics, Inc. | 1.54% |
| 23 | SLS | SELLAS Life Sciences Group, Inc. | 1.51% |
| 24 | VERA | Vera Therapeutics, Inc. | 1.50% |
| 25 | MLYS | Mineralys Therapeutics, Inc. | 1.46% |
As of Sep 24, 2026